Norgine Ventures

Norgine Ventures was started in 2012 Norgine Ventures provides debt and debt-like financing to innovative, fast-growing companies in the fields of healthcare and life sciences, in Europe and the US

To date, Norgine Ventures has invested in a number of businesses, including specialty pharma, diagnostic, digital health and medical device companies, at various stages of their life cycle, both in Europe and in the US

Norgine Ventures were unbelievable. We were a very young company with not much track record, but with a vision. Norgine Ventures believed in us and provided much needed financing at the right time on extremely good financial terms… Working with the team was fantastic… We exited extremely well a few years later and if it was not for Norgine Ventures we would not have achieved what we did.”

CEO of a European pharmaceutical company

Norgine Ventures has committed funds in excess of €170m to healthcare companies in Europe and in the US.

Norgine Ventures Management Limited, Norgine House, Widewater Place, Moorhall Road, Harefield, Uxbridge, UB9 6NS UK Norgine Ventures Management Limited is a limited company registered in England and Wales with company number 08723417 NORGINE and the sail logo are trademarks of the Norgine group of companies

Norgine Ventures Management Limited is authorised and regulated by the Financial Conduct Authority, registration number 917803

Investing in smaller and unlisted companies (which may be start-up or early stage businesses) involves risks These risks include possible loss of capital, illiquidity and dilution Such companies will often not pay dividends You should not invest in any such company (or any fund that invests in such companies) unless you understand the risks involved, and have taken advice where necessary A more detailed statement of risks involved can be found here Risk Warning